Attends Daily Barrier
NDC 62450-001
Product Information
Attends Daily Barrier is a OTC MONOGRAPH FINAL-approved product labeled by Purna Pharmaceuticals Nv. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 62450-001 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 62450-001?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ZINC OXIDE (UNII: SOI2LOH54Z)
- ZINC CATION (UNII: 13S1S8SF37) (Active Moiety)
- DIMETHICONE (UNII: 92RU3N3Y1O)
- DIMETHICONE (UNII: 92RU3N3Y1O) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ALOE VERA LEAF (UNII: ZY81Z83H0X)
- WATER (UNII: 059QF0KO0R)
- C12-15 ALKYL BENZOATE (UNII: A9EJ3J61HQ)
- GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)
- CARNOSINE (UNII: 8HO6PVN24W)
- METHYLPARABEN (UNII: A2I8C7HI9T)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- PANTHENOL (UNII: WV9CM0O67Z)
- MINERAL OIL (UNII: T5L8T28FGP)
- PEG-100 STEARATE (UNII: YD01N1999R)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- PROPYLPARABEN (UNII: Z8IX2SC1OH)
- ALMOND OIL (UNII: 66YXD4DKO9)
- SORBITAN MONOSTEARATE (UNII: NVZ4I0H58X)
- TOCOPHEROL (UNII: R0ZB2556P8)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1491554 - dimethicone 2 % / zinc oxide 4 % Topical Spray
- RxCUI: 1491554 - dimethicone 20 MG/ML / zinc oxide 40 MG/ML Topical Spray
- RxCUI: 1491554 - dimethicone 20 MG/ML / ZNO 40 MG/ML Topical Spray
* Please review the full disclaimer at the bottom of this page.